ALB and malaria: Human serum albumin (HSA) has been proposed as a viable antimalarial drug carrier due to its targeting potential towards malaria-infected erythrocytes, as well as excellent availability, biodegradability, non-toxicity and non-immunogenicity, which make it an excellent option for antimalarial drug delivery (Boateng-Marfo et al., 2018; Bhide et al., 2023).